OmniAb (OABI) Deferred Taxes (2022 - 2026)
OmniAb (OABI) reported Deferred Taxes of $442000.0 for Q1 2026, up 516.98% year-over-year from $71639.1 in Q1 2025, and up 216.01% quarter-over-quarter from -$381000.0 in Q4 2025.
OmniAb (OABI) Deferred Taxes (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Deferred Taxes data on file, last reported at $442000.0 in Q1 2026.
- Deferred Taxes for Q1 2026 came in at $442000.0, up 516.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$981000.0 (up 84.97% YoY), and the FY2025 annual result was -$1.5 million, up 83.09% from the prior year.
- Deferred Taxes advanced to $442000.0 in Q1 2026 per OABI's latest filing, from -$381000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $442000.0 in Q1 2026 and troughed at -$5.1 million in Q4 2023.
- A 5-year average of -$1.7 million and a median of -$1.9 million in 2024 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2023 and 2026: Deferred Taxes tumbled 1304.99% in 2023, then jumped 516.98% in 2026.
- A 5-year view of Deferred Taxes shows it stood at $421000.0 in 2022, then plunged by 1304.99% to -$5.1 million in 2023, then surged by 64.18% to -$1.8 million in 2024, then soared by 79.03% to -$381000.0 in 2025, then jumped by 216.01% to $442000.0 in 2026.
- Business Quant data shows OABI's Deferred Taxes at $442000.0 in Q1 2026, -$381000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 442,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 442,000.00 |
| Dec 31, 2025 | -381,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -1.90 Mn |
| Mar 31, 2024 | -2.62 Mn |
| Dec 31, 2023 | -5.07 Mn |
| Sep 30, 2023 | -3.32 Mn |
| Jun 30, 2023 | -3.21 Mn |
| Mar 31, 2023 | -941,000.00 |
| Dec 31, 2022 | 421,000.00 |
| Sep 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -2.46 Mn |
| Mar 31, 2022 | -2.02 Mn |